The Vasculitis Clinical Research Consortium (VCRC) is a founding member, in 2003, of the Rare Diseases Clinical Research Network (RDCRN). The VCRC is the major clinical research infrastructure in North America dedicated to the study of vasculitis. The VCRC has grown to include 17 academic medical centers in the United States and Canada conducting investigator-initiated clinical and translational research. The VCRC also partners with 50 other centers worldwide for the conduct of clinical trials. The VCRC conducts observational cohort studies, biomarker development, studies of genetics and genomics, clinical outcomes research, studies using an online patient registry, pilot clinical projects, and multicentered, randomized clinical trials. Core components of the VCRC include the VCRC Clinical Data Repository, The VCRC Biospecimen Repository, The VCRC Patient Contact Registry, the VCRC-NIH Data and Safety Monitoring Board. The VCRC also hosts a public website providing information to patients about vasculitis and our research programs. The VCRC-VF Fellowship provides support for 2-years of mentored training focused on clinical care and research in vasculitis. Partnership with Patient Advocacy Groups has been a critical component of the success of the VCRC. The VCRC currently has over 1,880 patients enrolled in clinical research projects in 6 types of vasculitis. The VCRC Patient Contact Registry and electronic resources are important for patients worldwide. The VCRC Fellowship Program in Clinical Investigation has successfully trained new clinical investigators, each of whom remains engaged in academic research in vasculitis. VCRC Investigators have successfully obtained ancillary funding to allow for the expansion of the Consortium work. This proposal outlines 11 separate clinical protocols/programs, the VCRC Pilot Project Program, and the VCRC Fellowship. This application seeks refunding of the VCRC to support the critical administrative, clinical, laboratory, and biostatistical cores, allow completion of ongoing project, launch of exciting new scientific initiatives, train new investigators in clinical research in vasculitis, and expand the VCRC online activities

Public Health Relevance

The Vasculitis Clinical Research Consortium (VCRC) was established in in 2003 and is now the major clinical research infrastructure in North America dedicated to the study of vasculitis. By conducting a series of longitudinal cohort studies, biomarker and genetic discovery programs, clinical outcomes projects, multicenter clinical trials, pilot projects, running an online patient registry, and training Fellows, the Consortium is addressing serious unmet medical and scientific needs for this group of rare diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54AR057319-12
Application #
8764119
Study Section
Special Emphasis Panel ()
Program Officer
Wang, Yan Z
Project Start
2003-09-30
Project End
2019-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
12
Fiscal Year
2014
Total Cost
$1,250,000
Indirect Cost
$277,450
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Bingham 3rd, Clifton O; Bartlett, Susan J; Merkel, Peter A et al. (2016) Using patient-reported outcomes and PROMIS in research and clinical applications: experiences from the PCORI pilot projects. Qual Life Res 25:2109-16
Kermani, Tanaz A; Cuthbertson, David; Carette, Simon et al. (2016) The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. J Rheumatol 43:1078-84
Sy, Alice; Khalidi, Nader; Dehghan, Natasha et al. (2016) Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum 45:475-82
Merkel, Peter A; Manion, Michele; Gopal-Srivastava, Rashmi et al. (2016) The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 11:66
Tamura, Roy N; Krischer, Jeffrey P; Pagnoux, Christian et al. (2016) A small n sequential multiple assignment randomized trial design for use in rare disease research. Contemp Clin Trials 46:48-51
Pagnoux, C; Carette, S; Khalidi, N A et al. (2015) Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clin Exp Rheumatol 33:S-77-83
Kermani, Tanaz A; Warrington, Kenneth J; Cuthbertson, David et al. (2015) Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. J Rheumatol 42:1213-7
Hatemi, Gulen; Ozguler, Yesim; Direskeneli, Haner et al. (2015) Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014. J Rheumatol 42:2436-41
Aydin, Sibel Zehra; Direskeneli, Haner; Sreih, Antoine et al. (2015) Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12. J Rheumatol 42:2465-9
Dejaco, Christian; Oppl, Bastian; Monach, Paul et al. (2015) Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss). PLoS One 10:e0121737

Showing the most recent 10 out of 59 publications